[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100515784":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":22,"locations":28,"responsibleParty":368,"collaborators":370,"id":373,"slug":21,"hasResults":374,"nctId":375,"briefTitle":376,"officialTitle":377,"acronym":21,"eligibilityCriteria":378,"healthyVolunteers":374,"sex":379,"minAge":380,"maxAge":381,"enrollmentInfo":382,"targetDuration":21,"studyType":385,"phases":386,"briefSummary":388,"conditions":389,"keywords":393,"overallStatus":31,"whyStopped":21,"lastUpdateSubmitDate":395,"lastUpdatePostDateStruct":396,"startDateStruct":399,"completionDateStruct":401,"leadSponsor":403,"locationsCount":404},{"fullName":5,"class":6},"NS Pharma, Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"NS-089\u002FNCNP-02","EXPERIMENTAL","Experimental: NS-089\u002FNCNP-02\n\nNS-089\u002FNCNP-02 solution for infusion (Cohort 1)\n\nNS-089\u002FNCNP-02 solution for infusion (Cohort 2)",[13],"Drug: NS-089\u002FNCNP-02",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DRUG","Cohort 1:\n\nPart 1 Dose Level 1-3: a 4-week Treatment Phase at each treatment dose level\n\nPart 2 Single Dose Level: a 24-week Treatment Phase at the MTD of Part 1\n\nCohort 2:\n\nPart 2 Single Dose Level: a 24-week Treatment Phase at the MTD of Part 1",[9],[20],"Brogidirsen",null,[23],{"name":24,"role":25,"phone":26,"phoneExt":21,"email":27},"Trial info","CONTACT","1-866-677-6276","trialinfo@nspharma.com",[29,46,60,74,91,105,119,133,146,160,174,190,204,217,230,241,255,269,278,288,302,316,328,342,355],{"facility":30,"status":31,"city":32,"state":33,"zip":34,"country":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Children's Hospital Colorado","RECRUITING","Aurora","Colorado","80045","United States",{"type":37,"coordinates":38},"Point",[39,40],-104.83192,39.72943,{"lat":40,"lon":39},[43],{"name":44,"role":25,"phone":21,"phoneExt":21,"email":45},"Hannah Kleiner","hannah.kleiner@childrenscolorado.org",{"facility":47,"status":31,"city":48,"state":49,"zip":50,"country":35,"cosmosGeoPoint":51,"geoPoint":55,"contacts":56},"Rare Disease Research, LLC - FL","Kissimmee","Florida","34746",{"type":37,"coordinates":52},[53,54],-81.41667,28.30468,{"lat":54,"lon":53},[57],{"name":58,"role":25,"phone":21,"phoneExt":21,"email":59},"Marcial Almaraz","marcial.almaraz@rarediseaseresearch.com",{"facility":61,"status":31,"city":62,"state":63,"zip":64,"country":35,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"Rare Disease Research","Atlanta","Georgia","30329",{"type":37,"coordinates":66},[67,68],-84.38798,33.749,{"lat":68,"lon":67},[71],{"name":72,"role":25,"phone":21,"phoneExt":21,"email":73},"Julia Zhu","julia.zhu@rarediseaseresearch.com",{"facility":75,"status":31,"city":76,"state":77,"zip":78,"country":35,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"Ann and Robert H. Lurie Children's Hospital of Chicago","Chicago","Illinois","60611",{"type":37,"coordinates":80},[81,82],-87.65005,41.85003,{"lat":82,"lon":81},[85,88],{"name":86,"role":25,"phone":21,"phoneExt":21,"email":87},"Raven Hill","rhill@luriechildrens.org",{"name":89,"role":25,"phone":21,"phoneExt":21,"email":90},"Alka Maheshwari","amaheshwari@luriechildrens.org",{"facility":92,"status":31,"city":93,"state":94,"zip":95,"country":35,"cosmosGeoPoint":96,"geoPoint":100,"contacts":101},"University of Kansas Medical Center (KUMC)","Kansas City","Kansas","66160",{"type":37,"coordinates":97},[98,99],-94.62746,39.11417,{"lat":99,"lon":98},[102],{"name":103,"role":25,"phone":21,"phoneExt":21,"email":104},"Rebecca Clay","rclay@kumc.edu",{"facility":106,"status":31,"city":107,"state":108,"zip":109,"country":35,"cosmosGeoPoint":110,"geoPoint":114,"contacts":115},"Cincinnati Children's Hospital Medical Center","Cincinnati","Ohio","45229",{"type":37,"coordinates":111},[112,113],-84.51439,39.12711,{"lat":113,"lon":112},[116],{"name":117,"role":25,"phone":21,"phoneExt":21,"email":118},"Angela Edmondson","Angela.Edmondson@cchmc.org",{"facility":120,"status":31,"city":121,"state":122,"zip":123,"country":35,"cosmosGeoPoint":124,"geoPoint":128,"contacts":129},"The Children's Hospital of Philadelphia (CHOP)","Philadelphia","Pennsylvania","19104",{"type":37,"coordinates":125},[126,127],-75.16362,39.95238,{"lat":127,"lon":126},[130],{"name":131,"role":25,"phone":21,"phoneExt":21,"email":132},"Karen Monono","mononok@email.chop.edu",{"facility":134,"status":31,"city":135,"state":122,"zip":136,"country":35,"cosmosGeoPoint":137,"geoPoint":141,"contacts":142},"University of Pittsburgh School of Medicine","Pittsburgh","15224",{"type":37,"coordinates":138},[139,140],-79.99589,40.44062,{"lat":140,"lon":139},[143],{"name":144,"role":25,"phone":21,"phoneExt":21,"email":145},"Vibha Chauhan","vibha.chauhan@chp.edu",{"facility":147,"status":31,"city":148,"state":149,"zip":150,"country":35,"cosmosGeoPoint":151,"geoPoint":155,"contacts":156},"UT Southwestern\u002FChildren's Health","Dallas","Texas","75207",{"type":37,"coordinates":152},[153,154],-96.80667,32.78306,{"lat":154,"lon":153},[157],{"name":158,"role":25,"phone":21,"phoneExt":21,"email":159},"Deniece Winston","Deniece.Winston@UTSouthwestern.edu",{"facility":161,"status":31,"city":162,"state":163,"zip":164,"country":35,"cosmosGeoPoint":165,"geoPoint":169,"contacts":170},"Virginia Commonwealth University Health System","Richmond","Virginia","23298",{"type":37,"coordinates":166},[167,168],-77.46026,37.55376,{"lat":168,"lon":167},[171],{"name":172,"role":25,"phone":21,"phoneExt":21,"email":173},"Andrea Jewell","andrea.jewell@vcuhealth.org",{"facility":175,"status":176,"city":177,"state":178,"zip":179,"country":180,"cosmosGeoPoint":181,"geoPoint":185,"contacts":186},"Perth Children's Hospital","NOT_YET_RECRUITING","Nedlands","Western Australia","6009","Australia",{"type":37,"coordinates":182},[183,184],115.8073,-31.98184,{"lat":184,"lon":183},[187],{"name":188,"role":25,"phone":21,"phoneExt":21,"email":189},"Jane Jones","Jane.Jones2@health.wa.gov.au",{"facility":191,"status":176,"city":192,"state":193,"zip":21,"country":194,"cosmosGeoPoint":195,"geoPoint":199,"contacts":200},"Alberta Children's Hospital","Calgary","Alberta","Canada",{"type":37,"coordinates":196},[197,198],-114.08529,51.05011,{"lat":198,"lon":197},[201],{"name":202,"role":25,"phone":21,"phoneExt":21,"email":203},"Julie Dao","julie.dao@ucalgary.ca",{"facility":205,"status":176,"city":206,"state":207,"zip":21,"country":194,"cosmosGeoPoint":208,"geoPoint":212,"contacts":213},"British Columbia Children's Hospital","Vancouver","British Columbia",{"type":37,"coordinates":209},[210,211],-123.11934,49.24966,{"lat":211,"lon":210},[214],{"name":215,"role":25,"phone":21,"phoneExt":21,"email":216},"Gabe Massarotto","gabe.massarotto@cw.bc.ca",{"facility":218,"status":31,"city":219,"state":220,"zip":21,"country":194,"cosmosGeoPoint":221,"geoPoint":225,"contacts":226},"London Health Sciences Centre","London","Ontario",{"type":37,"coordinates":222},[223,224],-81.23304,42.98339,{"lat":224,"lon":223},[227],{"name":228,"role":25,"phone":21,"phoneExt":21,"email":229},"Rhiannon Hicks","rhiannon.hicks@lhsc.on.ca",{"facility":231,"status":176,"city":232,"state":233,"zip":234,"country":235,"cosmosGeoPoint":236,"geoPoint":240,"contacts":21},"Fukui Prefectural Hospital","Fukui-shi","Fukui","910-8526","Japan",{"type":37,"coordinates":237},[238,239],136.22257,36.06443,{"lat":239,"lon":238},{"facility":242,"status":31,"city":243,"state":244,"zip":245,"country":235,"cosmosGeoPoint":246,"geoPoint":250,"contacts":251},"National Hospital Organization Nagara Medical Center","Nagara","Gifu-shi, Gifu","502-8558",{"type":37,"coordinates":247},[248,249],129.25,28.25,{"lat":249,"lon":248},[252],{"name":253,"role":25,"phone":21,"phoneExt":21,"email":254},"Clinical Trial Management Office","yonekura.kei.wu@mail.hosp.go.jp",{"facility":256,"status":176,"city":257,"state":258,"zip":259,"country":235,"cosmosGeoPoint":260,"geoPoint":264,"contacts":265},"NHO Osaka Toneyama Medical Center","Toyonaka","Osaka","560-8552",{"type":37,"coordinates":261},[262,263],135.46932,34.78244,{"lat":263,"lon":262},[266],{"name":267,"role":25,"phone":21,"phoneExt":21,"email":268},"Clinical Trial Office","410-chiken@mail.hosp.go.jp",{"facility":270,"status":176,"city":271,"state":272,"zip":273,"country":235,"cosmosGeoPoint":21,"geoPoint":21,"contacts":274},"Shiga General Hospital","Moriyama-shi","Shiga","524-8524",[275],{"name":276,"role":25,"phone":21,"phoneExt":21,"email":277},"Children's Building","kenji.s.address@gmail.com",{"facility":279,"status":176,"city":280,"state":281,"zip":282,"country":235,"cosmosGeoPoint":283,"geoPoint":287,"contacts":21},"National Center of Neurology and Psychiatry","Kodaira","Tokyo","187-8551",{"type":37,"coordinates":284},[285,286],139.48508,35.72603,{"lat":286,"lon":285},{"facility":289,"status":176,"city":290,"state":21,"zip":291,"country":292,"cosmosGeoPoint":293,"geoPoint":297,"contacts":298},"Starship Children's Hospital","Auckland","1023","New Zealand",{"type":37,"coordinates":294},[295,296],174.76349,-36.84853,{"lat":296,"lon":295},[299],{"name":300,"role":25,"phone":21,"phoneExt":21,"email":301},"Margaret Joppa","mjoppa@adhb.govt.nz",{"facility":303,"status":176,"city":304,"state":305,"zip":21,"country":306,"cosmosGeoPoint":307,"geoPoint":311,"contacts":312},"Pusan National University Yangsan Hospital","Yangsan","Gyeongsangnam","South Korea",{"type":37,"coordinates":308},[309,310],129.03358,35.34199,{"lat":310,"lon":309},[313],{"name":314,"role":25,"phone":21,"phoneExt":21,"email":315},"JaeYoon Kim","lusterwuzz@naver.com",{"facility":317,"status":176,"city":318,"state":21,"zip":21,"country":306,"cosmosGeoPoint":319,"geoPoint":323,"contacts":324},"Seoul National University Hospital","Seoul",{"type":37,"coordinates":320},[321,322],126.9784,37.566,{"lat":322,"lon":321},[325],{"name":326,"role":25,"phone":21,"phoneExt":21,"email":327},"Hyeon Ju Kwon","hjkwon@snuh.org; 49041@snuh.org",{"facility":329,"status":176,"city":330,"state":21,"zip":331,"country":332,"cosmosGeoPoint":333,"geoPoint":337,"contacts":338},"Ankara Bilkent City Hospital","Ankara","06800","Turkey (Türkiye)",{"type":37,"coordinates":334},[335,336],32.85427,39.91987,{"lat":336,"lon":335},[339],{"name":340,"role":25,"phone":21,"phoneExt":21,"email":341},"Gozde Akgun","gozde.akgun@medex-smo.com",{"facility":343,"status":176,"city":344,"state":21,"zip":345,"country":332,"cosmosGeoPoint":346,"geoPoint":350,"contacts":351},"Yeditepe University Kosuyolu Hospital","Istanbul","34718",{"type":37,"coordinates":347},[348,349],28.94966,41.01384,{"lat":349,"lon":348},[352],{"name":353,"role":25,"phone":21,"phoneExt":21,"email":354},"Onur Güner","onurguner@ascotscience.com",{"facility":356,"status":176,"city":357,"state":21,"zip":358,"country":332,"cosmosGeoPoint":359,"geoPoint":363,"contacts":364},"S.B.U. Dr. Behcet uz Pediatric Diseases and Surgery Training and Research Hospital","Izmir","11794",{"type":37,"coordinates":360},[361,362],27.13838,38.41273,{"lat":362,"lon":361},[365],{"name":366,"role":25,"phone":21,"phoneExt":21,"email":367},"Zeynep Erturk","zeyneperturk@ascotscience.com",{"type":369,"investigatorFullName":21,"investigatorTitle":21,"investigatorAffiliation":21,"oldNameTitle":21,"oldOrganization":21},"SPONSOR",[371],{"name":372,"class":6},"Nippon Shinyaku Co., Ltd.","100515784",false,"NCT05996003","NS-089\u002FNCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)","A Phase 2 Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of NS-089\u002FNCNP-02 in Boys With Duchenne Muscular Dystrophy (DMD)","Inclusion Criteria:\n\n* Male ≥ 4 years and \\\u003C15 years of age\n* Confirmed DMD mutation(s) in the dystrophin gene that is amenable to skipping of exon 44 to restore the dystrophin mRNA reading frame\n* Able to walk independently without assistive devices\n* Ability to complete the TTSTAND without assistance in \\\u003C20 seconds\n* Stable dose of glucocorticoid for at least 3 months and the dose is expected to remain on a stable dose for the duration of the study.\n* Other inclusion criteria may apply.\n\nExclusion Criteria:\n\n* Has a body weight of \\\u003C20 kg at the time of informed consent (applies to participants screening for Part 1 only)\n* Evidence of symptomatic cardiomyopathy\n* Current or previous treatment with anabolic steroids (e.g., oxandrolone) or products containing resveratrol or adenosine triphosphate within 3 months prior to first dose of study drug\n* Current or previous treatment with any other investigational drug within 3 months prior to the first dose of study drug or within 5 times the half-life of a medication, whichever is longer\n* Surgery within the 3 months prior to the first dose of study drug or planned during the study duration\n* Previously treated in an interventional study of NS-089\u002FNCNP-02\n* Having received exon skipping oligonucleotide within 1 year prior to the first dose of IP\n* Other exclusion criteria may apply.","MALE","4 Years","14 Years",{"count":383,"type":384},20,"ESTIMATED","INTERVENTIONAL",[387],"PHASE2","This is a Phase 2, open-label, multi-center, 2-part study of NS-089\u002FNCNP-02 administered by weekly IV infusion to ambulant boys aged ≥4 to \\\u003C15 years with DMD due to mutations amenable to exon 44 skipping. Participants will receive a selected dose of NS-089\u002FNCNP-02 administered once weekly.\n\nThe study consists of 2 parts: Part 1 and Part 2. Six participants (Cohort 1) will participate in both Part 1 and Part 2, and 14 participants (Cohort 2) will be added for Part 2.",[390,391,392],"Duchenne Muscular Dystrophy","Exon 44","DMD",[394,392,20],"Exon 44 Skipping","2026-03-04",{"date":397,"type":398},"2026-03-06","ACTUAL",{"date":400,"type":398},"2024-02-22",{"date":402,"type":384},"2026-09-11",{"name":5,"class":6},25]